Prasad has been involved in several controversial decisions related to rare disease treatments.
WASHINGTON — Vinay Prasad, a top official at the Food and Drug Administration who has been at the center of recurring public controversies, is exiting the agency for a second time.
Prasad will leave the FDA at the end of April, and his replacement has not yet been identified, FDA Commissioner Marty Makary
told The Wall Street Journal
.
Read the rest…
— Source: STAT News (https://www.statnews.com/2026/03/06/fda-vinay-prasad-controversial-cber-director-leaving/)
